New York cancer centre invests in sequence analysis software
5 November 2008Tweet
The Memorial Sloan-Kettering Cancer Center in New York has extended its broad site license agreement with DNAStar for the use of the latter's Lasergene sequence analysis software.
Under the terms of the three-year site license, Lasergene will continue to available to all researchers at the centre's New York City location. Lasergene can be used on assembly and analysis applications for projects using both conventional and next generation sequencing platforms.